|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/4188 | |
| A61K 31/505 | |||
| A61K 31/519 | |||
| A61P 35/00 |
| (11) | Number of the document | 3086787 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14824115.1 |
| Date of filing the European patent application | 2014-12-19 | |
| (97) | Date of publication of the European application | 2016-11-02 |
| (45) | Date of publication and mention of the grant of the patent | 2021-01-20 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2014/067141 |
| Date | 2014-12-19 |
| (87) | Number | WO 2015/097622 |
| Date | 2015-07-02 |
| (30) | Number | Date | Country code |
| 201361920032 P | 2013-12-23 | US | |
| 201461948323 P | 2014-03-05 | US | |
| 201462078571 P | 2014-11-12 | US |
| (72) |
FERRETTI, Stephane, CH
JEAY, Sebastien, CH
HALILOVIC, Ensar, US
LI, Fang, US
WANG, Hui-qin, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | PHARMACEUTICAL COMBINATIONS |
| PHARMACEUTICAL COMBINATIONS |